Hypertonic Saline Infusion for Hyponatremia: Limitations of the Adrogué-Madias and Other Formulas
Kidney360 · 2023
DOI: 10.34067/kid.0000000000000075 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney360, 2023. Verfasst von Brent Wagner und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, University of New Mexico School of Medicine, Albuquerque, New Mexico. Hauptthemen laut MEDLINE: Hyponatremia. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCATS NIH HHS.
Abstract (Originalsprache)
Hypertonic saline infusion is used to correct hyponatremia with severe symptoms. The selection of the volume of infused hypertonic saline ( V Inf ) should address prevention of overcorrection or undercorrection. Several formulas computing this V Inf have been proposed. The limitations common to these formulas consist of (1) failure to include potential determinants of change in serum sodium concentration ([ Na ]) including exchanges between osmotically active and inactive sodium compartments, changes in hydrogen binding of body water to hydrophilic compounds, and genetic influences and (2) inaccurate estimates of baseline body water entered in any formula and of gains or losses of water, sodium, and potassium during treatment entered in formulas that account for such gains or losses. In addition, computing V Inf from the Adrogué-Madias formula by a calculation assuming a linear relation between V Inf and increase in [ Na ] is a source of errors because the relation between these two variables was proven to be curvilinear. However, these errors were shown to be negligible by a comparison of estimates of V Inf by the Adrogué-Madias formula and by a formula using the same determinants of the change in [ Na ] and the curvilinear relation between this change and V Inf . Regardless of the method used to correct hyponatremia, monitoring [ Na ] and changes in external balances of water, sodium, and potassium during treatment remain imperative.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, University of New Mexico School of Medicine, Albuquerque, New Mexico.
- Research Service, Raymond G. Murphy Veterans Affairs Medical Center, Albuquerque, New Mexico.
- Kidney Institute of New Mexico, University of New Mexico Health Sciences Center, Albuquerque, New Mexico.
- Division of Nephrology, University of Toledo College of Medicine, Toledo, Ohio.
- Division of Nephrology, George Washington University School of Medicine, Washington, DC.
- Division of Nephrology, Joan C. Edwards School of Medicine, Marshall University, Huntington, West Virginia.
ORCID-Profile: Brent Wagner
Förderung
- NCATS NIH HHS
Zitieren
APA
Wagner, B., Malhotra, D., Schmidt, D., Raj, D. S., Khitan, Z. J., Shapiro, J. I., & Tzamaloukas, A. H. (2023). Hypertonic Saline Infusion for Hyponatremia: Limitations of the Adrogué-Madias and Other Formulas. Kidney360. https://doi.org/10.34067/kid.0000000000000075
Vancouver
Wagner B, Malhotra D, Schmidt D, Raj DS, Khitan ZJ, Shapiro JI, et al. Hypertonic Saline Infusion for Hyponatremia: Limitations of the Adrogué-Madias and Other Formulas. Kidney360. 2023. doi:10.34067/kid.0000000000000075
BibTeX
@article{Wagner2023,
author = {Wagner, Brent and Malhotra, Deepak and Schmidt, Darren and Raj, Dominic S and Khitan, Zeid J and Shapiro, Joseph I and Tzamaloukas, Antonios H},
title = {Hypertonic Saline Infusion for Hyponatremia: Limitations of the Adrogué-Madias and Other Formulas},
journal = {Kidney360},
year = {2023},
doi = {10.34067/kid.0000000000000075}
}
EUVIMED